Migration is not the perfect answer: How the cross‐talk error correction for multiple breath nitrogen washout (MBWN2) parameters differs on directly collected vs. legacy data. Issue 1 (4th October 2022)

• Record Type: Journal Article
• Authors: Short, Christopher; Abkir, Mary; Pinnell, Sophie; Proctor, Owain; Saunders, Clare J.; Davies, Jane C.
• Is Part Of: Pediatric pulmonology. Volume 58:Issue 1(2023)
• Page Start: 328
• Page End: 331
• Publication Date: 2022-10-04
• Subjects: biomarkers -- cystic fibrosis (CF) -- lung clearance index (LCI) -- lung function testing -- multiple breath washout (MBW) -- pulmonary function testing (PFT) -- pulmonary physiology; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.26169
• Languages: English
• ISSNs: 8755-6863

Abstract

Abstract: Recently, a cross‐talk error with commercial multiple breath nitrogen washout (MBWN2 ) software was discovered, which produced an absolute over‐reading of N2 of approximately 1%, i.e., 2% N2 read as 3%. This caused an extended tail to the washout, and over‐estimated lung clearance index (LCI2.5 ) values. Subsequently an updated and corrected software version has been released. Within the field there have been discussions on how to correct legacy data, whether to migrate or completely "rerun" raw data A‐files from the old software into the new corrected software. To our knowledge, no research has been published assessing whether either method is equivalent to directly collecting data in the new corrected software. We prospectively recruited 19 participants, 10 adult healthy controls and 9 people with cystic fibrosis (CF). MBWN2 was performed using the Exhalyzer® D first on the old 3.1.6 software and next, directly on corrected 3.3.1 software. Multiple breath washout (MBW) data directly collected in 3.3.1 was significantly different from both migrated and rerun data. A total of 7 of the 19 participants (37%; 4 CF) had a relative difference in LCI2.5 > 10% for both migrated and rerun data compared to 3.3.1 collected data. Our findings have implications for the Global Lung Initiative MBW project, which is accepting a combination of directly collected, A‐file reruns and migrated data to establish normative values. Further, caution must be used in clinical practice when comparing corrected legacy data versus 3.3.1 collected data for clinical interpretation. We recommend that a new baseline is collected directly on 3.3.1. before clinical interpretation and decisions are determined when comparing consecutive MBW tests.